1. Home
  2. RMD vs HLN Comparison

RMD vs HLN Comparison

Compare RMD & HLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ResMed Inc.

RMD

ResMed Inc.

HOLD

Current Price

$245.15

Market Cap

36.4B

Sector

Health Care

ML Signal

HOLD

Logo Haleon plc (Each representing two)

HLN

Haleon plc (Each representing two)

HOLD

Current Price

$10.15

Market Cap

41.7B

ML Signal

HOLD

Company Overview

Basic Information
Metric
RMD
HLN
Founded
1989
2022
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Package Goods/Cosmetics
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
36.4B
41.7B
IPO Year
1995
N/A

Fundamental Metrics

Financial Performance
Metric
RMD
HLN
Price
$245.15
$10.15
Analyst Decision
Buy
Hold
Analyst Count
13
1
Target Price
$289.09
N/A
AVG Volume (30 Days)
924.4K
10.1M
Earning Date
01-29-2026
07-31-2025
Dividend Yield
0.98%
1.79%
EPS Growth
29.59
41.64
EPS
9.77
0.23
Revenue
$5,257,400,000.00
$15,096,588,575.00
Revenue This Year
$9.85
$1.51
Revenue Next Year
$7.36
$4.67
P/E Ratio
$25.05
$21.47
Revenue Growth
9.36
N/A
52 Week Low
$199.92
$8.71
52 Week High
$293.81
$11.42

Technical Indicators

Market Signals
Indicator
RMD
HLN
Relative Strength Index (RSI) 43.12 66.93
Support Level $241.66 $9.82
Resistance Level $247.45 $9.65
Average True Range (ATR) 4.94 0.13
MACD -0.28 0.05
Stochastic Oscillator 18.66 97.09

Price Performance

Historical Comparison
RMD
HLN

About RMD ResMed Inc.

ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.

About HLN Haleon plc (Each representing two)

Haleon is one of the largest consumer health companies in the world. Formed by a combination of consumer health divisions of GSK, Pfizer, and Novartis, Haleon separated from GSK and went public in July 2022. The firm generates 60% of sales from global power brands including Sensodyne, Advil, Centrum, and Poligrip, that play in many geographies and are often leaders in their respective categories. It also has a number of local brands, including Emergen-C, Eno, Tums, and Caltrate, that are more tailored to regional needs and have strong local brand equity. Overall, Haleon's brands tackle a variety of silos within consumer health including oral care, digestive health, pain relief, and nutrition.

Share on Social Networks: